(April 24, 2019, 1:39 PM EDT) -- NEW YORK — In what a U.S. attorney described as a first-of-its-kind action, the United States on April 23 secured a consent decree and a $20 million penalty from a pharmaceutical distributor for unlawfully distributing the opioids oxycodone and fentanyl and announced a guilty plea by the company’s chief compliance officer and indictment of its CEO for the same conduct (United States of America v. Rochester Drug Co-Operative, No. 19-cv-3568, United States of America v. Laurence F. Doud III, No. 19-cr-285, United States of America v. William Pietruszewski, No. n/a, United States of America v. Rochester Drug Co-Operative, Inc., No. n/a, S.D. N.Y.)....